Content oversight and quality assurance provided by Studio 1847 Health care-associated infections pose a persistent and tremendous threat to patient safety. According to the Centers for Disease ...

Clinical pharmacology is a branch of biomedical science. It includes drug discovery, the study of the effects of drugs on their targets in living systems and their clinical use, as well as the ...

has announced plans to advance the clinical development of stenoparib, a dual PARP/Wnt pathway inhibitor, for FDA approval in advanced ovarian cancer. The new Phase 2 protocol will optimize ...

Information related to the IRB submission process. The UB IRB has updated the HRP-503 Template Protocol (IRB Version: JAN2016). All new studies submitted on or after April 1, 2016 must be submitted ...

Amgen AMGN reported fourth-quarter 2024 adjusted earnings of $5.31 per share, which beat the Zacks Consensus Estimate of $5.03 per share. Earnings rose 13% year over year as higher revenues were ...

Cross-species transplantation will now be tested in human clinical trials in the US. (HealthDay News) — The US Food and Drug Administration (FDA) has approved the first-ever clinical trials ...

Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug application from Ocugen, Inc. was approved by the Food and Drug Administration (FDA).

A clinical trial is one that involves human participants and seeks to answer specific questions about a type of medical intervention. This can be a drug or other type of treatment, such as nutritional ...

The US Food and Drug Administration has greenlit clinical trails for organ transplants ... has also indicated plants to engage with the FDA after the first six transplants are completed.

Amgen’s mysterious obesity asset will remain a mystery for a bit longer—the FDA has put the candidate’s phase 1 trial on a clinical hold, the company announced Feb. 4. Amgen has not detailed ...

Languages: English That has some policy experts confused about the FDA's ability to implement efficient recalls and protect Americans from foodborne illness or public health hazards. More ...

Auron has received clearance of its Investigational New Drug (IND) application by the U.S. Food and Drug Administration (FDA) and is initiating clinical development of AUTX-703 in hematological ...